During a House Energy Committee hearing before the Congressional Recess, Rep. Greg Landsman (R-OH) asked Acting Director for Center for Drug Evaluation and Research at the FDA Dr. Jacqueline Corrigan-Curay about wait times for new OTC drugs with updated FDA guidance.<br />
